Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3614_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
73 Мб
Скачать
SECTION 7 Technical aspects ofcoronary artery bypass graft surgery398
https://t.me/medicina_free
76. Esposito ML, Zhang Y, Qiao X, Reyelt L, Paruchuri V, Schnitzler GR, etal. Le ventricular unloading before reperfusion promotes functional recovery aer acute myocardial infarction. J Am Coll Cardiol. 2018;72(5):501– 14.
77. Kirklin JK, Nael DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, etal. Seventh INTERMACS annual report:15,000 patients and counting. J Heart Lung Transplant. 2015;34(12):1495– 504.
78. Dang NC, Topkara VK, Leacche M, John R, Byrne JG, Naka Y. Le ventricular assist device implantation aer acute anterior wall myocardial infarction and cardiogenic shock:a two- center study. J orac Cardiovasc Surg. 2005;130(3):693– 8.
79. Adamo L, Nassif M, Tibrewala A, Novak E, Vader J, Silvestry SC, etal. e Heartmate Risk Score predicts morbidity and mortality in unselected le ventricular assist device recipients and risk straties INTERMACS class 1 patients. JACC Heart Fail. 2015;3(4):283– 90.
80. Mehra MR, Goldstein DJ, Uriel N, Cleveland JC, Yuzefpolskaya M, Salerno CT, etal. Two- year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2019;378(15):1386– 95.
81. Mehta P, Imamura T, Juricek C, Sarswat N, Kim G, Raikhelkar J, etal. Combined le ventricular assist device and coronary artery bypass graing surgery:should we bypass the bypass? ASAIO J. 2020;66(1):32– 7.
https://t.me/medicina_free
57
Prevention ofmediastinitis
Harold L. Lazar
Introduction
not possible to eliminate these risk factors. However, by instituting a series of interventions in the preoperative, intraoperative, and post-
Sternal wound infections resulting in mediastinitis occur in 1– 4% of patients undergoing coronary artery bypass gra (CABG) sur-
operative periods, the incidence of sternal wound infection can be signicantly decreased and mediastinitis virtually eliminated.
gery. Although the incidence of mediastinitis has decreased, it is still associated with increased morbidity and mortality and decreased long- term survival. Sternal infections prolong hospital stay, increase hospital readmissions, raise hospital costs, and are now publicly re­ported. In the United States, the Centers for Medicare & Medicaid Services will no longer reimburse the extra hospital costs for treating deep sternal wound infections (DSWIs) following CABG surgery.
Although bilateral internal thoracic artery (BITA) graing has been shown to prolong survival, its use has been curtailed, especially in diabetic patients, because of the concern of the increased risk for sternal wound infections and mediastinitis.
is chapter will review the preoperative, intraoperative, and postoperative principles to prevent sternal wound infections and mediastinitis following CABG surgery.
Interventions toprevent sternal wound infections andmediastinitis
Preoperativeprevention
Nasaldisinfectants
Twenty to thirty per cent of the general population are Staphylococcus species carriers. e predominant organism found in cardiac wound infections is Staphylococcus that originates from the patient’s own nasal ora. erefore, all CABG patients should have nasal swab testing prior to surgery. However, the results of nasal swab cultures may not be available in those patients who require urgent or emer­gent surgery. Polymerase chain reaction (PCR) assays provide a more rapid screening (<12 hours) for Staphylococcus carriers; although
Definitions
Sternal wound infections may be supercial (SSWIs) or deep (DSWIs). ASSWI involves the skin, subcutaneous tissue, and may extend to the pectoralis fascia, but not to the bone. ADSWI involves the bone and mediastinal space and is associated with fever, sternal instability, purulent mediastinal drainage, and positive deep tissue and, possibly, blood cultures.
they add to medical costs and are not available in all hospitals.
Topical intranasal therapies are the best method to eradicate Staphylococcus colonization; mupirocin ointment (Bactroban®, GlaxoSmithKline, Brentford, UK) appears to have great ecacy in treating Staphylococcus nasal carriers. It has been shown in retro­spective, single- centre studies to decrease the incidence of sternal wound infections. Nasal mupirocin has no eect in patients who are not nasal staphylococcal carriers and in patients with a negative PCR assay. Furthermore, it only decolonizes 45– 50% of methicillin­resistant Staphylococcus aureus (MRSA) carriers. erefore,
Risk factors fordeveloping sternal wound infection andmediastinitis
mupirocin nasal ointment should only be used in those patients who have a positive nasal culture for staphylococcal species or a posi­tive PCR assay and in those patients in whom culture results are not available or cannot be obtained at the time of surgery. It should be
Patients with obesity, chronic renal failure, chronic obstructive pul­monary disease, diabetes mellitus, peripheral vascular disease, and those who require hospitalization prior to their CABG surgery are at higher risk for developing a postoperative wound infection and mediastinitis. Unfortunately, these risk factors are found in the majority of patients undergoing CABG surgery today. Since most CABG patients require surgery on an urgent or emergent basis, it is
administered within 24 hours of surgery and continued for 5days.
Topical intranasal use of iodine- based polymicrobial disinfectant (povidone- iodine, Betadine®, 3M, St. Paul, MN, USA) solution has also been proposed and adopted by many centres as a more con­venient intranasal therapy. is treatment has the advantage of being eective against all nasal ora, regardless of the patient’s car­rier status, and being almost immediately eective aer a single
SECTION 7 Technical aspects ofcoronary artery bypass graft surgery400
https://t.me/medicina_free
application, even if administered only in the preoperative holding area just prior to surgery. is simple, one- time application reduces nasal bacteria, including S. aureus, by 99.5% in just 1 hour and maintains this reduction for at least 12 hours. In direct comparison against mupirocin, intranasal povidone- iodine solution was more eective in reducing nasal ora.
Presurgicalbathing
Preoperative showering with chlorhexidine gluconate is recom­mended to reduce surgical site infections and has been shown to decrease bacterial skin counts to a greater extent than other agents. However, randomized controlled trials showed no dierence in the postoperative wound infection rates between patients who showered with chlorhexidine gluconate, povidone- iodine soap and water, or placebo. While presurgical bathing reduces the skin microbial burden that can contribute to wound infections and mediastinitis, it alone cannot prevent skin ora organisms from contaminating the surgical wound during CABG surgery.
Preoperative hairremoval
Preoperative hair removal should be performed with clippers, and not razors, to minimize skin abrasions that can colonize with organ­isms from the patient’s own skin ora. It should not be performed in the operating room to minimize the risk of contaminating the sterile eld.
Poor nutritionalstatus
Patients with poor nutritional status and those with hypoalbuminaemia (serum albumen concentration <2.5 g/ mL) prior to cardiac surgery have a signicantly higher incidence of DSWIs, mediastinitis, and mortality. Elderly patients and those patients with a serum albumen concentration less than 2.5g/ mL and a weight loss of greater than 10% of total body weight within 6months of surgery appear to be the most vulnerable. Preoperative nutritional support should be instituted in those patients in whom surgery can be safely delayed for 7– 10days. is approach has been shown to decrease wound infections and sepsis following major abdominal surgery. e enteral route is pre­ferred since it avoids volume overload, metabolic derangements, and line sepsis, and is more cost- eective.
Preoperative extrathoracicinfections
Infections which are present at a site remote from the planned car­diac incision, especially those involving the urinary tract, lungs, abdominal organs, and so tissues, signicantly increase the inci­dence of postoperative wound infections. In non- urgent/ emergent situations, the organisms involved should be identied and appro­priate antibiotics promptly instituted until the infection has totally resolved.
Optimizing preoperative glycaemiccontrol
Increased serum glucose levels (>200 mg/ dL) prior to cardiac surgical procedures have been shown to signicantly increase the incidence of sternal wound infections, especially in those diabetic patients in whom glycated haemoglobin levels exceed 7.5%. Reducing serum glucose to less than 200 mg/ dL signicantly decreases the incidence of sternal wound infections in patients with diabetes mellitus. In
those CABG patients who require urgent or emergent surgery with glucose levels greater than 200 mg/ dL, optimizing glycaemic control is best accomplished by using intravenous insulin infusions. is is now a classIrecommendation in the Society of oracic Surgeons (STS) guidelines for blood glucose management during adult car­diac surgery.
Smoking cessation and aggressive pulmonarytoilet
Active smoking at the time of cardiac surgery is an independent risk factor for sternal infections and mediastinitis, especially in patients greater than 70years of age. Although the exact time for cessation of smoking prior to surgery is unknown, it is recommended that, whenever possible, patients should stop smoking for at least 30days prior to surgery. In those patients who either cannot quit smoking or who require urgent/ emergent CABG and are actively smoking, preoperative pulmonary physiotherapy can help to loosen secre­tions and minimize mucus plugging which results in prolonged ven­tilation, increased coughing, and respiratory infections, all of which contribute to sternal instability, wound dehiscence, and ultimately mediastinitis.
Preoperativeantibiotics
Preoperative antibiotics are essential to decrease the incidence of wound infections and mediastinitis following cardiac surgical procedures. In 2006– 2007, the STS Workforce on Evidence- Based Medicine published a series of guidelines for the duration and choice of antibiotics during cardiac surgical procedures., e following is a summary of their recommendations:
• Acephalosporin, either cefazolin or cefuroxime, should be given
within 60 minutes prior to the skin incision (classIrecommenda­tion, level of evidence A).
• Vancomycin should be reserved for patients with type Iallergic
reactions to a beta- lactam agent or in cases where MRSA is of concern. ese include patients hospitalized for more than 3days, patients transferred from another inpatient facility, procedures involving a prosthetic valve or a vascular gra, and institutions with a high prevalence of MRSA (classII recommendation, level of evidence B).
• Since vancomycin is less active against S. aureus strains, the most
common organisms found in DSWIs, vancomycin is not recom­mended as the sole prophylactic antibiotic for cardiac surgery procedures (classIII recommendation, level of evidence B).
• An aminoglycoside should be added preoperatively for Gram-
negative coverage when vancomycin is the primary prophylactic antibiotic since vancomycin’s activity is limited to Gram- positive bacteria; specically MRSA and methicillin- resistant S. epidermidis (classIIB recommendation, level of evidence C).
Intraoperativeprevention
Antibiotics
Since cardiac surgery procedures usually last longer than 4 hours and antibiotic levels may be altered during cardiopulmonary bypass, the STS guidelines recommend that cephalosporins be re- dosed for procedures lasting longer than 4 hours. Weight- based dosing is re­commended (classIrecommendation, level of evidence A).
57 Prevention ofmediastinitis 401
https://t.me/medicina_free
Instruments
Flashing instruments, especially larger instruments such as sternal retractors and retractors used for the dissection of the internal thoracic artery (ITA), should be avoided. Instruments used for harvesting saphenous veins and those used for groin cannulation should not be used in the mediastinum. is increases the risk for cross- contamination of surgical wounds and ultimately sternal wound infections and mediastinitis.
Glycaemiccontrol
Elevated glucose levels (>200 mg/ dL) during surgery are an inde­pendent risk factor for postoperative sternal wound infections, while maintaining serum glucose less than 180 mg/ dL decreases the incidence of sternal wound infections. STS guidelines recommend that patients with persistently elevated serum glucose levels greater than 180 mg/ dL during surgery should receive a continuous intra­venous insulin infusion to maintain serum glucose levels at less than 180 mg/ dL.
Topicalantibiotics
Topical antibiotics applied to the cut edges of the sternum in either a dry or powdered form achieve much higher local wound concen­trations than are possible with systemic antibiotics and these high
Vander Salm et al., in a prospective randomized trial of patients undergoing a median sternotomy, found that vancomycin applied topically to the edges of the sternum reduced the rate of sternal wound infections from 3.6% to 0.5% (P=0.02). Lazar et al., in a retro­spective, non- randomized study involving over 3000 sternotomy patients, found that topical vancomycin applied as a slurry to both edges of the sternum in conjunction with perioperative antibiotics and tight glycaemic control (<180 mg/ dL), totally eliminated super­cial (0% vs 1.6%; P <0.001), deep (0% vs 0.7%; P=0.005), or any type of wound infection in both non- diabetic (0% vs 2.2%; P <0.0001) and diabetic patients (0% vs 3.3%; P=0.0004). Furthermore, in a dierent study, Lazar etal. found that when applied topically to the sternum, serum levels of vancomycin returned to baseline by the sixth postoperative day, and there was no increase in drug- resistant infections or postoperative renal toxicity. Gentamycin– collagen sponges have also been shown to reduce the incidence of both super­cial and DSWIs by 40%. It is, however, important to limit the ex­posure of the gentamycin sponges in saline prior to implantation to avoid decreasing the concentration of the gentamycin in the sponges.
Bone wax should beavoided
Bone wax should not be applied to the sternum during cardiac sur­gery. It acts as a foreign body, prevents bone union, and has been found to be an independent risk factor for sternal dehiscence and infections. Furthermore, it has not been shown to limit blood loss or the use of blood products. Vancomycin paste, applied to the cut edges of the sternum, is helpful in reducing bleeding from the sternum, without the deleterious eects of bone wax.
Haemostasis and adequatedrainage
All surgeons are aware of the importance of minimizing exces­sive intraoperative bleeding, and achieving haemostasis. Excessive
bleeding and haematoma formation result in a culture medium that promotes bacterial growth and leads to mediastinitis. Blood transfusions may also contribute to postoperative infections and should be kept to a minimum. Excessive use of topical haemostatic agents may also elicit an inammatory response which predisposes to mediastinitis. When diuse oozing is present due to an under­lying coagulopathy, adequate drainage of the mediastinum and pleural cavities is essential. Aer the coagulopathy is treated and clots form, proper location of drainage tubes which are appropri­ately ‘stripped’ will minimize the amount of retained mediastinal blood and decrease the incidence of mediastinitis.
Intraoperative techniques tomaintain sternalstability
Minimizing postoperative sternal infections and mediastinitis starts with performing a midline sternotomy. An inadvertent paramedian sternotomy is oen accompanied by a sternal fracture, and increases the risk for instability, dehiscence, and ultimately infection. When this occurs, a ‘Robicsek weave’, in which wires are woven through the intercostal spaces parasternally in conjunction with standard trans­verse wires, can decrease the incidence of sternal dehiscence.
For routine sternal closures without fractures, a gure- of- eight technique has been found to decrease the incidence of supercial and deep sternal infections, especially when cable wires are used.
Rigid sternal xation with bands or plates have been used in obese, diabetic, and chronic obstructive pulmonary disease patients to reduce the incidence of dehiscence in these high- risk patients. e results are inconclusive; they are more expensive and have been associated with wound seromas and haematomas. ey should not be used in patients with osteoporosis and in the presence of active infections.
Minimizing sternal infections inpatients withBITAgrafts
Although BITA graing has been shown to increase long- term sur­vival in CABG patients, it is associated with a higher risk of DSWIs. e risk appears to be signicantly higher in patients with long­standing and insulin- dependent diabetes mellitus. Skeletonization of BITAs signicantly decreases the incidence of wound infections in all patients, similar to the incidence observed when only a single ITA is used. e use of a modied pedicle harvesting technique for BITAs, in which the bifurcation of the distal ITA to the chest wall and the pericardiophrenic artery branch are preserved, has also been shown to decrease the incidence of sternal wound infections. ese techniques will help to decrease BITA- related sternal wound infections and increase the use of BITA graing in all patients. e most recent (2018) European Society of Cardiology/ European Association for Cardio- oracic Surgery Guidelines on myocardial revascularization now recommend skeletonizing the ITA in patients with a high risk for sternal wound infections (classIB).
Postoperativeprevention
Antibiotics
STS guidelines now recommend that appropriate antibiotics should be continued for no longer than 48 hours following surgery. Vancomycin, when used with a cephalosporin, and aminoglycosides, when used with vancomycin, should each be given for one add­itional postoperative dose.
SECTION 7 Technical aspects ofcoronary artery bypass graft surgery402
https://t.me/medicina_free
Glycaemiccontrol
STS guidelines now recommend that serum glucose concentration be less than 180 mg/ dL for the rst 24 hours in the intensive care unit using intravenous insulin infusions. Insulin infusions should con­tinue in those patients in whom extended periods of intensive care unit care are necessary due to the need for inotropic support, mech­anical ventilatory or circulatory assistance, or antiarrhythmic therapy.
Chest wallstabilization
Early extubation and suppression of uncontrolled coughing episodes prevents sternal instability and dehiscence which lead to infection. External chest support devices have also been used to prevent move­ment of the sternal tables. However, these vests are cumbersome to wear and patient compliance is variable.
Drainage and indwellingcatheters
As noted previously, retained blood which develops into a coagulum is an excellent culture medium and increases the risk for mediastin­itis. Every eort should be made to maintain patency of drainage catheters to remove any retained blood. ese catheters should be removed as soon as the drainage decreases since they also serve as a potential nidus for infection. In those instances where patients re­quire re- exploration for bleeding, this should done expeditiously
3. Anderson MJ, David ML, Scholz M, Bull SJ, Morse D, Hulse­Stevens M, etal. Ecacy of skin and nasal povidone- iodine preparation against mupirocin- resistant methicillin- resistant Staphylococcus aureus and S. aureus within the anterior nares. Antimicrob Agents Chemother. 2015;59(5):2765– 73.
4. Phillips M, Rosenberg A, Shopsin B, Cu G, Skeete F, Foti A, etal. Preventing surgical site infections:a randomized, open- label trial of nasal mupirocin ointment and nasal povidone- iodine solution. Infect Control Hosp Epidemiol. 2014;35(7):826– 32.
5. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infections. Infect Control Hosp Epidemiol. 1999;20(4):250– 78.
6. Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition. 2012;28(10):1022– 7.
7. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass gra patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109(12):1497– 502.
8. Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, etal. e Society of oracic Surgeons Practice Guideline Series:blood glucose management during adult cardiac surgery. Ann orac Surg. 2009;87(2):663– 9.
9. Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR, Society of oracic Surgeons. e Society of oracic Surgeons
to minimize the need for blood transfusions which contribute to sternal wound infections. When patients are returned to the oper­ating room for re- exploration, appropriate antibiotics should be re­dosed and topical antibiotics should be reapplied to the sternal edges.
Finally, indwelling urinary, central venous, and peripheral ar­terial catheters should be removed as soon as the patients are clin­ically stable and invasive haemodynamic monitoring is no longer necessary.
Practice Guideline Series:antibiotic prophylaxis in cardiac surgery, part i:duration. Ann orac Surg. 2006;81(1):397– 404.
10. Engelman RM, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, etal. e Society of oracic Surgeons practice guideline series:antibiotic prophylaxis in cardiac surgery, part II:antibiotic choice. Ann orac Surg. 2007;83(4):1569– 76.
11. Halasz NA. Wound infection and topical antibiotics:the surgeon’s dilemma. Arch Surg. 1977;112(10):1240– 4.
12. Vander Salm TJ, Okike ON, Pasque MK, Pezzella AT, Lew R, Traina V, etal. Reduction of sternal infection by application of
Conclusion
topical vancomycin. J orac Cardiovasc Surg. 1989;98(4):618– 22.
13. Lazar HL, Ketchedjian A, Haime M, Karlson K, Cabral H. Topical vancomycin in combination with perioperative antibiotics
e prevention of sternal wound infections and mediastinitis is multifactorial and requires a team eort among surgeons, refer­ring physicians, nurses, and operating room and intensive care unit personnel. Implementing the recommendations described in this chapter has the potential to decrease the incidence of sternal infec­tions and mediastinitis to less than 0.5% in all patients undergoing CABG surgery. is will encourage the increased use of BITA gras, decrease postoperative morbidity and mortality, decrease hospital costs, and ultimately increase long- term survival.
and tight glycemic control helps to eliminate sternal wound infections. J orac Cardiovasc Surg. 2014;148(3):1035– 8.
14. Lazar HL, Barlam T, Cabral H. e eect of topical vancomycin applied to sternotomy incisions on postoperative serum vancomycin levels. J Card Surg. 2011;26(5):461– 5.
15. Kowalewski M, Pawliszak W, Zaborowska K, Navarese EP, Szwed KA, Kowalkowska ME, etal. Gentamicin- collagen sponge reduces the risk of sternal wound infections aer heart surgery:meta- analysis. J orac Cardiovasc Surg. 2015;149(6):1631– 40.
16. Deo SV, Shah IK, Dunlay SM, Erwin PJ, Locker C, Altarabsheh SE, etal. Bilateral internal thoracic artery harvest and deep
REFERENCES
1. Huang SS, Rifas- Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES, etal. Improving methicillin- resistant staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis. 2007;195(3):330– 8.
2. Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection aer open heart surgery in diabetics and nondiabetics. Ann orac Surg. 2001;71(5):1572– 8.
sternal wound infection in diabetic patients. Ann orac Surg. 2013;95(3):862– 9.
17. Sajja LR, Mannam G, Dandu SBR, Sompalli S. Reduction of sternal wound infections in diabetic patients undergoing o­pump coronary artery bypass surgery using modied pedicle bilateral internal thoracic artery harvest technique. J orac Cardiovasc Surg. 2012;144(2):480– 5.
18. Neuman FJ, Sousa- Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, etal. ESC/ EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87– 165.
https://t.me/medicina_free
SECTION 8
Coronary artery bypass gra surgery inspecial situations
Section editors:Naresh Trehan and Yasir Abu-Omar
58. Coronary artery bypass grafting in women 405
Jessica Yu Rove and Jennifer S.Lawton
59. Coronary artery bypass grafting in
octogenarians 411
Derrick Y.Tam, Reena Karkhanis, and Stephen E.Fremes
60. Coronary artery bypass graft surgery in the setting
of acute myocardial infarction 415
Babatunde A.Yerokun and Peter K.Smith
61. Coronary artery bypass grafting in patients with
ventricular dysfunction:indications, techniques, and outcomes 419
Andrea Garatti, Serenella Castelvecchio, Alessandro Parolari, and Lorenzo Menicanti
62. Coronary artery bypass grafting:diabetes and
kidney disease 423
Michael E.Farkouh and Valentin Fuster
63. Coronary artery bypass grafting with surgical
ventricular reconstruction 431
Serenella Castelvecchio, Raffaella Molfetta, Andrea Garatti, and Lorenzo Menicanti
64. Coronary anomalies:indications and technique,
including anomalous coronary arteries and coronary artery fistulas 435
Anita Nguyen, Ramachandra C.Reddy, and Hartzell V.Schaff
https://t.me/medicina_free
https://t.me/medicina_free
58
Coronary artery bypass graing inwomen
Jessica Yu Rove and Jennifer S. Lawton
Introduction
is chapter acknowledges perceived and actual dierences in the manifestation of coronary artery disease between women and men. Further, it summarizes data on the modern performance and outcomes of coronary artery bypass surgery in women compared to men.
Epidemiology ofcoronary artery disease inwomen
Cardiovascular disease is the number one cause of death for adult women in the United States and every major developed country of the world. Between 1984 and 2013 in the United States, more women than men died annually of cardiovascular disease. In 2016, 412,244 American women died from cardiovascular diseases, accounting for almost a quarter of female deaths that year., is disease burden is not simply due to women’s longevity as compared with men. Ischaemic heart disease is the leading killer of women, with annual mortality rates that aect more women under the age of 55years than breast cancer (Fig. 58.1).,
In addition to traditional risk factors for atherosclerotic coronary disease, such as diabetes, smoking, obesity, inactivity, hyperten­sion, and dyslipidaemia, there are non-traditional risk factors for coronary disease in women such as preterm delivery, hyperten­sive disorders of pregnancy, gestational diabetes, autoimmune dis­ease (rheumatoid arthritis and lupus), breast cancer radiation and chemotherapy, and depression (Fig. 58.2)., Furthermore, we now know that a diagnosis of diabetes puts women at 50% greater risk of coronary artery disease compared to the same diagnosis in men., In 2011, the American Heart Association released an update on ‘Eectiveness-based guidelines for the prevention of coronary artery disease in women’ and recommended risk-stratifying women based on their risk scores in three categories:(1) high risk, (2)at risk, and (3)optimal risk (Fig. 58.3).
Evaluation ofcoronary artery disease inwomen
Physician evaluation of coronary artery disease in women is predi­cated on recognizing the risk of heart disease in female patients. It is striking that only 8% of primary care providers and 17% of cardi­ologists in 2005 knew that heart disease killed more women every year than men. Despite the American Heart Association’s release of ‘Evidence-based guidelines for cardiovascular disease preven­tion in women’ in 2004, the risk of heart disease in women is still under-recognized by physicians. Women are more likely than men to be assigned a lower Framingham risk category despite a similar calculated risk., Furthermore, when presenting with symptoms of myocardial ischaemia, women are less likely than men to be re­ferred for cardiac catheterization., When women undergo cardiac catheterization for evidence of myocardial ischaemia, they are less likely than men to be diagnosed with obstructive coronary artery disease.,, With increased utilization of fractional ow reserve to objectively assess coronary lesions, one propensity-matched study showed that female patients referred for catheterization have lower fractional ow reserve values compared to men for a given angio­graphic appearance of coronary stenosis.
Revascularization inwomen
Acknowledging the substantial burden of coronary artery disease in women, it is surprising that less than a third of patients enrolled in studies on the management of acute coronary syndrome and cor­onary artery bypass graing (CABG) are women.– e numbers in these studies mirror statistics that show bypass graing is oered to women at a lower rate than to men. In a contemporary analysis of a coronary artery disease registry, male sex was signicantly asso­ciated with referral for CABG versus percutaneous coronary inter­vention (odds ratio 2.27; P <0.001). According to the National Center for Health Statistics in the United States, approximately 450,000 bypass operations are performed per year and roughly 30%
SECTION 8 Coronary artery bypass graft surgery inspecial situations406
450,000
Deaths
Traditional ASCVD Risk Factors
Emerging, Nontraditional ASCVD Risk Factors
https://t.me/medicina_free
400,000
350,000
300,000
250,000
200,000
150,000
100,000
50,000
Males Females
0
CVD
428,434 412,244
Cancer Accidents CLRDDiabetes
314,571 283,467
103,864
57,510
Causes of Deaths
Males Females
73,045 81,551
43,763 36,295
Alzheimer’s
Disease
35,372 80,731
Fig.58.1 Bar graph showing cardiovascular disease and other major causes of death for all males and females in the United States:2016. CLRD,
chronic lower respiratory disease; CVD, cardiovascular disease.
Source data from National Center for Health Statistics and National Heart, Lung, and Blood Institute.
are performed for women. Interestingly, more women than men undergo emergent CABG.,
Unique perioperative recommendations for women under­going surgical revascularization have been described. e Society of oracic Surgeons (STS) Workforce on Evidence-Based Surgery has issued guidelines for the perioperative management of women undergoing coronary artery bypass surgery. In addition, there are
Diabetes
noteworthy technical considerations specic to revascularization in women.,
Complete revascularization and target coronarysize
ere is angiographic and intraoperative evidence that women have smaller coronary arteries compared to men., When ad­justed for body surface area, women have coronaries that are,
Preterm delivery
Obesity and overweight
Fig.58.2 Traditional and non-traditional atherosclerotic cardiovascular disease (ASCVD) risk factors in women. Increasing among women and more
impactful traditional ASCVD risk factors include diabetes mellitus, hypertension, dyslipidaemia, smoking, obesity, and physical inactivity. Emerging, non-traditional ASCVD risk factors include preterm delivery, hypertensive pregnancy disorders, gestational diabetes mellitus, breast cancer treatments, autoimmune diseases, and depression.
Reproduced from Garcia M, Mulvagh SL, Merz CN, Buring JE, Manson JE. Cardiovascular disease in women:clinical perspectives. Circ Res 2016;118:1273–93 with permission from Wolters Kluwer.
Smoking
Physical inactivity
Hypertension
Dyslipidemia
Hypertensive disorders of pregnancy
Gestational diabetes
Autoimmune disease
Breast cancer treatment
Depression
58 Coronary artery bypass grafting inwomen 407
Risk status
High risk (≥1 high-risk states)
At risk (≥1 major risk factor[s])
Ideal cardiovascular health (all of these)
Systemic autoimmune collagen-vascular diseases
https://t.me/medicina_free
Fig.58.3 Classification of cardiovascular disease risk in women. BP,
blood pressure; CHD, coronary heart disease; DASH, dietary approaches to stop hypertension; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; IMT, intima–media thickness; SBP, systolic blood pressure; wk, weeks; y, years.
Reproduced from Mosca L, Benjamin EJ, Berra K etal. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update:a guideline from the American Heart Association. Circulation 2011;123:1243–62 with permission from Wolters Kluwer.
angiographically, 0.3 mm on average smaller than those of men of the same body size. In another study that measured coronary arteries intraoperatively, women more frequently had coronaries smaller than 1.25 mm. In particular, women had signicantly smaller le anterior descending arteries compared to men. In
Criteria
Clinically manifest CHD
Clinically manifest cerebrovascular disease
Clinically manifest peripheral arterial disease
Abdominal aortic aneurysm
End-stage or chronic kidney disease
Diabetes mellitus
10-y predicted CVD risk ≥10%
Cigarette smoking
SBP ≥120 mmHg, DBP ≥80 mmHg, or treated hypertension
Total cholesterol ≥200 mg/dL, HDL-C <50 mg/dL, or treated for dyslipidemia
Obesity, particularly central adiposity
Poor diet
Physical inactivity
Family history of premature CVD occurring in first-degree relatives in men <55 y of age or in women <65 y of age
Metabolic syndrome
Evidence of advanced subclinical atherosclerosis (e.g. coronary calcification, carotid plaque, or thickened IMT)
Poor exercise capacity on treadmill test and/or
abnormal heart rate recovery after stopping exercise
(e.g. lupus or rheumatoid arthritis)
History or preeclampsia, gestational diabetes, or
pregnancy-induced hypertension
Total cholesterol <200 mg/dL (untreated)
BP <120/<80 mmHg (untreated)
Fasting blood glucose <100 mg/dL (untreated)
Body mass index <25 kg/m
Abstinence from smoking
Physical activity at goal for adults >20 y of age: ≥150 min/wk moderate intensity, ≥75 min/wk vigorous intensity, or combination
Healthy (DASH-like) diet
2
this study, the incidence of incomplete revascularization was also signicantly higher in women. Performing bypass surgery on smaller coronaries is understandably more technically challenging. Although graing small coronaries has not been associated with in­creased morbidity or mortality, the technical challenge of graing small coronaries may contribute to observed lower rates of complete revascularization. Complete revascularization to each suitable re­gion has been associated with reduced mortality.– In addition, incomplete revascularization has been associated with increased postoperative myocardial infarction, reintervention for early gra failure, and postoperative shock requiring mechanical support.
Graftchoice
Internal thoracic artery (ITA) utilization for CABG has been shown to improve both in-hospital and long-term survival and it is undisputedly the recommended conduit to bypass the le anterior descending artery.–  e STS guidelines for CABG in women make a classI(level of evidence B) recommendation to use at least one ITA gra to bypass a stenotic coronary in every CABG case. e use of an ITA is a quality measure for CABG endorsed by the National Quality Forum and the STS. ITA use is reported to the Centers for Medicare & Medicaid Services in the United States as a quality measure and a justication must be provided if it is not used. e le ITA use in men is 80–95%. In stark contrast, le ITA use in women has been only 50–75%. In fact, the STS National Cardiac Database identies female sex as an independent predictor for non-use of an ITA gra. Clearly a more concerted eort must be made to use an ITA conduit in women.
Multiple arterial graing using bilateral internal thoracic arteries (BITAs) and radial arteries is supported by American, European, and STS guidelines.– ere is strong evidence supporting superior pa­tency and improved survival with the use of BITA gras compared to saphenous vein gras in CABG., In addition, there are data demonstrating equivalent survival and postoperative complications between propensity-matched cohorts of men and women receiving BITA gras. Despite this evidence, only 5–10% of patients receive BITA gras and the utilization of BITA gras in women is half the rate of utilization in men.,
Although not as underutilized as the right ITA, the utilization of radial arteries in women is a paltry 10–20%., ere is growing evidence that radial artery graing in women not only yields su­perior patency to vein gras, but positively impacts survival., In a study including more than 300 women undergoing CABG with ra­dial artery gras who were propensity matched to over 1000 women undergoing CABG with saphenous vein gras, the use of radial artery conduit exhibited a signicant protective eect on survival from 5years out to 15years. is protective eect was associated with radial artery patency (80%) that was comparable to the le ITA (84%), at 15years and much superior to saphenous vein gras (56%). In another study that matched women undergoing CABG with saphenous vein gras to women who also received radial artery gras, survival at 5years was 82% in those receiving radial artery graing compared to 74% in the saphenous vein gra group. In an­other recent analysis of pooled patients from the randomized trials of radial artery utilization followed out to 5years, females who had radial artery conduits had fewer major adverse cardiac events and female sex was associated with a lower risk of radial artery conduit occlusion and a higher risk of saphenous vein gra occlusion.